These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 1828393)

  • 1. The retinoblastoma protein copurifies with E2F-I, an E1A-regulated inhibitor of the transcription factor E2F.
    Bagchi S; Weinmann R; Raychaudhuri P
    Cell; 1991 Jun; 65(6):1063-72. PubMed ID: 1828393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The E2F transcription factor is a cellular target for the RB protein.
    Chellappan SP; Hiebert S; Mudryj M; Horowitz JM; Nevins JR
    Cell; 1991 Jun; 65(6):1053-61. PubMed ID: 1828392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinoblastoma-repression of E2F-dependent transcription depends on the ability of the retinoblastoma protein to interact with E2F and is abrogated by the adenovirus E1A oncoprotein.
    Arroyo M; Raychaudhuri P
    Nucleic Acids Res; 1992 Nov; 20(22):5947-54. PubMed ID: 1461728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product.
    Chellappan S; Kraus VB; Kroger B; Munger K; Howley PM; Phelps WC; Nevins JR
    Proc Natl Acad Sci U S A; 1992 May; 89(10):4549-53. PubMed ID: 1316611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F.
    Hiebert SW; Chellappan SP; Horowitz JM; Nevins JR
    Genes Dev; 1992 Feb; 6(2):177-85. PubMed ID: 1531329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The T/E1A-binding domain of the retinoblastoma product can interact selectively with a sequence-specific DNA-binding protein.
    Chittenden T; Livingston DM; Kaelin WG
    Cell; 1991 Jun; 65(6):1073-82. PubMed ID: 1828394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complexes containing the retinoblastoma gene product recognize different DNA motifs related to the E2F binding site.
    Ouellette MM; Chen J; Wright WE; Shay JW
    Oncogene; 1992 Jun; 7(6):1075-81. PubMed ID: 1534398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus E1a prevents the retinoblastoma gene product from complexing with a cellular transcription factor.
    Bandara LR; La Thangue NB
    Nature; 1991 Jun; 351(6326):494-7. PubMed ID: 1710781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of distinct roles for separate E1A domains in disruption of E2F complexes.
    Ikeda MA; Nevins JR
    Mol Cell Biol; 1993 Nov; 13(11):7029-35. PubMed ID: 8413292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins.
    Nevins JR
    Science; 1992 Oct; 258(5081):424-9. PubMed ID: 1411535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E2F transcription factor is a target for the RB protein and the cyclin A protein.
    Nevins JR; Chellappan SP; Mudryj M; Hiebert S; Devoto S; Horowitz J; Hunter T; Pines J
    Cold Spring Harb Symp Quant Biol; 1991; 56():157-62. PubMed ID: 1840249
    [No Abstract]   [Full Text] [Related]  

  • 12. Protein domains governing interactions between E2F, the retinoblastoma gene product, and human papillomavirus type 16 E7 protein.
    Huang PS; Patrick DR; Edwards G; Goodhart PJ; Huber HE; Miles L; Garsky VM; Oliff A; Heimbrook DC
    Mol Cell Biol; 1993 Feb; 13(2):953-60. PubMed ID: 7678696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product.
    Flemington EK; Speck SH; Kaelin WG
    Proc Natl Acad Sci U S A; 1993 Aug; 90(15):6914-8. PubMed ID: 8346196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth factor beta through E2F binding sites.
    Li JM; Hu PP; Shen X; Yu Y; Wang XF
    Proc Natl Acad Sci U S A; 1997 May; 94(10):4948-53. PubMed ID: 9144170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Domains of the adenovirus E1A protein required for oncogenic activity are also required for dissociation of E2F transcription factor complexes.
    Raychaudhuri P; Bagchi S; Devoto SH; Kraus VB; Moran E; Nevins JR
    Genes Dev; 1991 Jul; 5(7):1200-11. PubMed ID: 1829698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus E1a prevents the retinoblastoma gene product from repressing the activity of a cellular transcription factor.
    Zamanian M; La Thangue NB
    EMBO J; 1992 Jul; 11(7):2603-10. PubMed ID: 1385776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The retinoblastoma protein region required for interaction with the E2F transcription factor includes the T/E1A binding and carboxy-terminal sequences.
    Huang S; Shin E; Sheppard KA; Chokroverty L; Shan B; Qian YW; Lee EY; Yee AS
    DNA Cell Biol; 1992 Sep; 11(7):539-48. PubMed ID: 1388726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin-dependent kinases phosphorylate the adenovirus E1A protein, enhancing its ability to bind pRb and disrupt pRb-E2F complexes.
    Mal A; Piotrkowski A; Harter ML
    J Virol; 1996 May; 70(5):2911-21. PubMed ID: 8627766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell cycle analysis of E2F in primary human T cells reveals novel E2F complexes and biochemically distinct forms of free E2F.
    Chittenden T; Livingston DM; DeCaprio JA
    Mol Cell Biol; 1993 Jul; 13(7):3975-83. PubMed ID: 8321204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties.
    Kaelin WG; Krek W; Sellers WR; DeCaprio JA; Ajchenbaum F; Fuchs CS; Chittenden T; Li Y; Farnham PJ; Blanar MA
    Cell; 1992 Jul; 70(2):351-64. PubMed ID: 1638635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.